Showing results (751-760 of 2,640) with videos related to
Sort By:
Pageof 264
Oncology Research|January 1, 1997
Differential effects of taxol on two human cancer cell linesS Banerjee, A G Fallis, D L BrownOncology Research|January 1, 1997
Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cellsO S Kremenetskaya, N P Logacheva, A Y Baryshnikov, et al.Oncology Research|January 1, 1997
Importance of glutathione and associated enzymes in drug responseH Shen, L Kauvar, K D TewOncology Research|January 1, 1997
Redox active disulfides: the thioredoxin system as a drug targetD L Kirkpatrick, G Ehrmantraut, S Stettner, et al.Oncology Research|January 1, 1997
Pure antiestrogens as a new therapy for breast cancerG M England, V C JordanOncology Research|January 1, 1997
Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cellsU Vanhoefer, W Voigt, R A Hilger, et al.Oncology Research|December 3, 2003
Epidermal growth factor-responsive laryngeal squamous cancer cell line Hep2 is more sensitive than unresponsive CO-K3 one to quercetin and tamoxifen apoptotic effectsG Raspaglio, G Ferrandina, C Ferlini, et al.Oncology Research|October 14, 2003
Reductive metabolism of the nitroimidazole-based hypoxia-selective cytotoxin NLCQ-1 (NSC 709257)Maria V Papadopoulou, Ming Ji, Mira K Rao, et al.Oncology Research|October 14, 2003
Increased activity and expression of phospholipase D2 in human colorectal cancerHirokazu Oshimoto, Shinichi Okamura, Makoto Yoshida, et al.Pageof 264